Symbol="PMCB"
AssetType="Common Stock"
Name="PharmaCyte Biotech Inc"
Description="PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United States. The company is headquartered in Laguna Hills, California."
CIK="1157075"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="MEDICINAL CHEMICALS & BOTANICAL PRODUCTS"
Address="23046 AVENIDA DE LA CARLOTA, SUITE 600, LAGUNA HILLS, CA, US"
FiscalYearEnd="April"
LatestQuarter="2023-01-31"
MarketCapitalization="23163500"
EBITDA="None"
PERatio="None"
PEGRatio="0"
BookValue="4.235"
DividendPerShare="0"
DividendYield="0"
EPS="-0.27"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.0519"
ReturnOnEquityTTM="-0.0666"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.27"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.654"
EVToRevenue="-"
EVToEBITDA="-11.23"
Beta="-0.0222"
num_52WeekHigh="3.23"
num_52WeekLow="2.34"
num_50DayMovingAverage="2.972"
num_200DayMovingAverage="2.937"
SharesOutstanding="8708100"
DividendDate="None"
ExDividendDate="None"
symbol="PMCB"
open="2.70"
high="2.73"
low="2.66"
price="2.66"
volume="17696.00"
latest_trading_day="2023-07-31"
previous_close="2.73"
change="-0.07"
change_percent="-2.5641%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="39"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="61"
Volume_recent_avg="56014"
Change_recent_avg="0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.02"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="61"
Aroon_momentum_negative="39"
image_negative_thumbnail_id_1="117"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0059.jpeg"
image_negative_thumbnail_id_2="491"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0114.jpeg"
image_neutral_thumbnail_id_1="595"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="664"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0044.jpeg"
image_positive_thumbnail_id_2="702"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0006.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
